Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

IDH mutation-specific radiomic signature in lower-grade gliomas

First author:Liu Xing,Li Yiming

Corresponding author:Wang Yinyan

isocitrate dehydrogenase lower grade gliomas progn

essential_information

  • Person in charge:Liu Xing,Li Yiming
  • Data Sources: OTHERS
  • Number of papers:OTHERS20190784
  • Published time:2019-01-29

2019-01-29

Published articles

Journal:Aging

Publication type: Research Paper

IF(IF): 5.515

PMID: 30696801 Link To Pubmed Full text Download

Background And Purpose

Method

In this study, we extracted quantitative image features from T2-weighted MR images and revealed that the isocitrate dehydrogenase (IDH) wild type and mutant lower grade gliomas (LGGs) differed in their expression of 146 radiomic descriptors.

Conclusion

This radiomic signature may provide a way to non-invasively discriminate lower-grade gliomas as with or without the IDH mutation.

Main results

The logistic regression model algorithm further reduced these to 86 features. The classification model could discriminate the two types in both the training and validation sets with area under the curve values of 1.0000 and 0.9932, respectively. The transcriptome-radiomic analysis revealed that these features were associated with the immune response, biological adhesion, and several malignant behaviors, all of which are consistent with biological processes that are differentially expressed in IDH wild type and IDH mutant LGGs. Finally, a prognostic signature showed an ability to stratify IDH mutant LGGs into high and low risk groups with distinctive outcomes. By extracting a large number of radiomic features, we identified an IDH mutation-specific radiomic signature with prognostic implications.